Nexgel, Inc. (NXGL) EBT Margin (2018 - 2025)
Nexgel's (NXGL) quarterly EBT Margin came in at 33.19% in Q4 2025, down 609.0% YoY from 6.52% in Q4 2024, and down 50.51% on a QoQ basis from 22.05% in Q3 2025.
Nexgel, Inc. (NXGL) EBT Margin (2018 - 2025) Analysis & Trends
Nexgel (NXGL) has 8 years of EBT Margin data on file, last reported at 33.19% in Q4 2025.
- Quarterly EBT Margin fell 609.0% year-over-year to 33.19% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 25.33% (up 1452.0% YoY) and the FY2025 annual result came in at 25.33%, up 1453.0% from the prior year.
- EBT Margin declined to 33.19% in Q4 2025, from 22.05% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 22.05% in Q3 2025 to a low of 463.64% in Q1 2022.
- A 5-year average of 137.78% and a median of 90.59% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2021 — EBT Margin soared 54311 bps — and 2022, when it tumbled 19997 bps.
- Tracing NXGL's EBT Margin over 5 years: stood at 331.14% in 2021, then soared by 63 bps to 123.66% in 2022, then rose by 11 bps to 109.7% in 2023, then soared by 75 bps to 27.1% in 2024, then retreated by 22 bps to 33.19% in 2025.
- The last three EBT Margin figures came in at 33.19% (Q4 2025), 22.05% (Q3 2025), and 22.19% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -33.19% |
| Sep 30, 2025 | -22.05% |
| Jun 30, 2025 | -22.19% |
| Mar 31, 2025 | -24.16% |
| Dec 31, 2024 | -27.10% |
| Sep 30, 2024 | -25.65% |
| Jun 30, 2024 | -67.99% |
| Mar 31, 2024 | -71.48% |
| Dec 31, 2023 | -109.70% |
| Sep 30, 2023 | -45.21% |
| Jun 30, 2023 | -55.01% |
| Mar 31, 2023 | -130.16% |
| Dec 31, 2022 | -123.66% |
| Sep 30, 2022 | -216.02% |
| Jun 30, 2022 | -184.49% |
| Mar 31, 2022 | -463.64% |
| Dec 31, 2021 | -331.14% |
| Sep 30, 2021 | -340.90% |
| Jun 30, 2021 | -198.08% |
| Mar 31, 2021 | -263.67% |